31 out any protection. One was major stroke and two were minor stroke. One embolic complication appeared in 39 cases treated under protection at the period of post-dilation. The embolic complication appeared at the period of pre-dilation without protection. One thrombo-embolic complication, one hyperperfusion syndrome, and one non-stroke death appeared in 81 cases treated under protection at pre and post-dilataion. One thrombo-embolic complication due to acute stent occlusion appeared in 79 cases treated under total protection using PercuSurge. However, we failed lesion crossing using PercuSurge in two cases with very tight stenosis. A naviballoon successfully crossed the lesion. The rate of ischemic complication was 21% in the group without protection, while it was 1.5% in group with various types of protection. The overall morbid/mortality rate in our series was 2.5%.
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Representative Case
A 56-year-old male was admitted to our hospital due to sudden onset of aphasia and moderate left hemiparesis . A low density area already appeared in the anterior part of the left middle cerebral artery . Angiogram on admission demonstrated the nearly total occlusion of the left internal carotid artery ( figure 1A) . The left anterior and middle cerebral artery was
Summary
We perfomed carotid artery stenting(C AS) in 215 patients from August 1997 to October 2003 mainly using the distal protection tec hnique. Our technique and clinical results are described in this paper.
Material and Methods
CAS was performed without protection in initial 14 cases. Protection was done only at the time of post-dilatation in next 39 cases using naviballoon system 8 . In the next 81 cases , CAS was performed under protection at the time of pre and post-dilataion using naviballoon system 8 . PercuSurge guardwire system was used for next 79 cases during CAS. Four cases, which had a risk of lesion crossing , were done under Parodi's anti-embolic system.
The characteristics of our method were that the lesion was fully dilated at the period of predilatation under protection and a stent was deployed. If sufficient gain was not obtained after stent deployment, post-dilatation was added under distal protection. This method was done for 160 cases. opacified via the right anterior communicating artery ( figure 1B) . He was treated conservatively for two weeks. His neurological condition got better and hemiparesis and aphasia remarkably improved. Follow-up angiogiogram revealed the pseudoocclusion of the left cervical internal carotid artery (figure1C). Intracranial portion of the IC A was opacified at the late capillary phase . PTA/stenting was planned to prevent from the recurrent embolic stroke from the left IC A and to keep the patenc y of the left cervical IC A for the treatment of the contralateral ICA stenosis in the future . Parodi's antiembolic system was used to prevent embolic complication during lesion crossing as well as PT A/stenting, because PercuSurge seemed difficult to cross the tight stenosis . The external carotid artery was occluded with a balloon catheter at its orifice . The common carotid artery was obliterated by inflation of the balloon of the 10.5 F catheter and the distal end of the catheter was connected to the 4 F sheath introduced in th femoral vein via a filter (figure 1D,E). A 0.014" microguidewire (Choice PT , Boston Scientific , U.S.A.) was introduced through the stenosis and a 4 x 20 mm PT A balloon catheter (Savvy, Johnson & J ohnson, U.S.A) was navigated to the lesion. The balloon was inflated for 60 seconds under 6 atm. Then, a 8 x 40 mm self-expanding stent (SMAR T, Johnson & J ohnson) was deployed to cover the entire lesion. Satisfactory dilataion was obtained without any neurological complication and any new ischemic lesion on MRI ( figure 1F ). Any further neurological deficit and restenosis did not appear during the six months follow-up period ( figure  1G ).
Results

Thrombo
Discussion
Embolic protection is one of the most important problems to improve the overall results of carotid stenting1-10). Various types of protection devices have been developed including distal balloon protection system, filter wires , and proximal flow control technique (Parodi' s system) 1, 5, 6, 8, 10 .
The results of carotid stenting improved after introduction of protection system as shown in our series (ischemic complication reduced from 21% to 1.5%) as well as recent reports. However, there still exists the discussion which protection system is better . Filterwires seem suitable for cases in which ischemic symptoms appear during carotid occlusion, but they are not used for curved lesions or tight stenosis . Parodi's antiembolic sytem is appropriate for cases with floating embolus in which embolic complication may appear during lesion crossing. The disadvantage of PercuSurge system is the softness of the tip of the wire. This system is difficult to treat the tight stenosis or curved lesion. For tight stenosis or curved lesion naviballoon system or Parodi's system is more suitable than PercuSurge . Lesion with floating thrombus, Parodi's system seems best to prevent embolic complication during lesion crossing .
Conclusions
The results of C AS will improve the use of appropriate protection systems for each lesion. 
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